Interpretation of the clinical practice guideline for treatment of rapidly progressive autosomal dominant polycystic kidney disease with tolvaptan
徐德超 马熠熠 梅长林
Chinese Journal of Nephrology . 2019, (5): 387 -392 .  DOI: 10.3760/cma.j.issn.1001-7097.2019.05.011